dimas

In a surprising turn of events, the U.S. Food and Drug Administration (FDA) recently withdrew its notice of a proposed study on kratom and psychedelics. On August 2, the FDA published a notice in the Federal Register for a 60-day comment period regarding a proposed study titled “Risk/Safety Considerations and Motivations for Purchase and Use …

FDA Reverses Course on Controversial Kratom and Psychedelics Study Read More »